Fundz

Applied StemCell, Inc. Strengthens Executive Leadership with Two Key Appointments

PRIVATEDec 04, 2023

Position

Chief Commercial Officer

Company

Applied StemCell

George Hong
george.hong@appliedstemcell.com
MilpitasBiotechnologyHealth CareGeneticsTherapeuticsresearch

Description

Applied StemCell Inc, a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer)

Company Information

Company

Applied StemCell

Location

521 Cottonwood Drive

Milpitas, California, United States

About

Applied StemCell is a biotechnology company founded in 2008 to empower industry and academic researchers with cutting-edge gene editing and induced pluripotent stem cell (iPSC) technologies. Today, the company continues to drive the discovery and development of advanced therapeutics with a strong focus on genome engineering products and services. Backed by patented technologies, Applied StemCell provides a clear intellectual property path to commercialization, enabling innovation across the life sciences sector.

Fundz sees it the moment Applied StemCell changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

George
Likely contact at this company
••••••••@••••••••

See George's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Applied StemCell's next move

Learn about Strategic plan

Applied StemCell changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.